| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.4B | $4.2B | $4.3B | $4.0B | $0.7B | $0.4B | $0.3B | $0.2B |
| Cost of Revenue | $1.2B | — | — | — | — | $0.9B | $0.9B | $0.7B |
| Gross Profit | $0.9B | — | — | — | — | $0.1B | $0.1B | $0.1B |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.1B | $0.0B |
| SG&A Expense | $0.7B | $1.0B | $1.0B | $1.0B | $0.8B | — | — | — |
| Operating Income | $-0.1B | $-1.3B | $0.2B | $0.3B | $-0.1B | $-0.1B | $0.1B | $0.1B |
| Net Income | $-0.4B | $-1.4B | $0.1B | $0.2B | $-0.0B | $-0.0B | $-0.0B | $-0.0B |
| EPS (Basic) | $-2.27 | $-7.88 | $0.51 | $0.85 | $-0.14 | $-0.43 | $-0.31 | $-0.30 |
| EPS (Diluted) | $-2.27 | $-7.88 | $0.50 | $0.82 | $-0.14 | $-0.43 | $-0.31 | $-0.30 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.3B | $7.6B | $9.1B | $8.6B | $7.7B | $2.0B | $2.0B | $1.1B |
| Current Assets | $5.9B | $1.6B | $1.6B | $1.5B | $1.2B | $0.9B | $0.8B | $0.5B |
| Cash & Equivalents | $0.9B | $0.4B | $0.4B | $0.2B | $0.4B | $0.4B | $0.1B | $0.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $4.4B | $0.8B | $0.9B | $1.2B | $0.9B | $0.4B | $0.5B | $0.3B |
| Stockholders' Equity | $2.1B | $2.4B | $3.9B | $3.8B | $3.7B | — | $0.8B | $0.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.4B | $0.4B | $-0.0B | $0.3B | $0.2B | $0.1B | $0.1B |
| Investing Cash Flow | $0.0B | $-0.3B | $-0.5B | $-0.5B | $-0.2B | $-0.1B | $-0.5B | $-0.0B |
| Capital Expenditures | $0.0B | $0.3B | $0.5B | $0.5B | $0.3B | $0.0B | $0.1B | $0.0B |
| Financing Cash Flow | $0.1B | $-0.0B | $0.4B | $0.4B | $-0.1B | $0.1B | $0.5B | $-0.1B |